GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human fto in complex with acylhydrazine inhibitor 16

Analyse Crystal structure of human fto in complex with acylhydrazine inhibitor 16 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4CXX
Type
protein
Length
434 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-ketoglutarate-dependent dioxygenase fto
EC
1.14.11.-
UniProt
Q9C0B1
Ligands
640, NI
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-ketoglutarate-dependent dioxygenase fto (EC 1.14.11.-)protein43440% helix, 22% strandQ9C0B1

Ligands and binding sites

  • 640 · (2E)-4-{N'-[4-(4-tert-Butyl-benzyl)-pyridine-3-carbonyl]-hydrazino}-4-oxo-but-2-enoic acid · ligand · chains A
  • NI · Nickel (II) ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13200.700.8338NI, 640
21630.550.8028empty

Compared structures

  • 4CXX · Crystal structure of human FTO in complex with acylhydrazine inhibitor 16 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9C0B1 · AlphaFold monomer V2.0 prediction for alpha-ketoglutarate-dependent dioxygenase fto… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.